This person is not registered. Is this you?


Profile Details
Yaning Wang
Affiliations:

Food and Drug Administration

 
,
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@yllucywang
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Antibodies, Cancer Biology, Cell Biology, Drug Design, Genomics, Oncology, Proteomics
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 3024 / 3065 (What's this?)
Accomplish Score: 43
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 118
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 5 (30 / 0)
  • While aberrant expression or splicing of metastasis genes conveys to cancers the ability to break through tissue barriers and disseminate, the genetic basis for organ preference in metastasis formation has remained incompletely understood. ()
  • The metastasis of cancer cells is a vital aspect of disease progression and therapy. ()
  • BACKGROUND: The AURA3 clinical trial has shown that advanced non-small cell lung cancer (NSCLC) patients with EGFR T790M mutations in circulating tumor DNA (ctDNA) could benefit from osimertinib. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.